GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

enlicitide   Click here for help

GtoPdb Ligand ID: 13944

Compound class: Peptide
Comment: Enlicitide (MK-0616) is a macrocyclic peptide oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor [2]. PCSK9 is a dyslipidemia drug target. Enlicitide binds to PCSK9 and prevents its protein-protein interaction with the low-density lipoprotein receptor, which ultimately reduces plasma LDL-C concentration. Formulated as the chloride salt or decanoate adduct [5] for clinical use. The core peptide sequence is cyclo-Ala-D-Ala-Phe-Trp-Pro-Thr-Tyr-Pro-NH
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1C(=O)N[C@H](CNC(=O)CCCCC[N+](C)(C)C)C(=O)N[C@H]2CC3=CC=CC(=C3)CNC(=O)CO[C@H]4CCN5[C@@H]4C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC6=CC=C(C=C6)OC)C(=O)N7CCC[C@@]7(C)C(=O)NCCC8=CC=C(C=C8)CN(CCCCCCN9C=C(C[C@@H](C5=O)NC2=O)C%10=C9C=CC(=C%10)F)C(=O)CCC(=O)N1
Isomeric SMILES C[C@H]1C(=O)N[C@@H](C(=O)N[C@H]2CC3=CC(=CC=C3)CNC(=O)CO[C@H]4CCN5[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N6CCC[C@]6(C(=O)NCCC7=CC=C(CN(CCCCCCN8C=C(C[C@@H](C5=O)NC2=O)C9=C8C=CC(=C9)F)C(=O)CCC(=O)N1)C=C7)C)CC%10=CC=C(C=C%10)OC)[C@@H](C)O)CNC(=O)CCCCC[N+](C)(C)C
InChI InChI=1S/C82H109FN14O15/c1-51-74(103)91-65(47-86-68(99)19-11-10-14-40-97(4,5)6)76(105)88-62-43-56-17-15-18-57(41-56)46-85-70(101)50-112-67-33-39-95-73(67)78(107)92-72(52(2)98)77(106)90-63(42-54-24-27-60(111-7)28-25-54)80(109)96-38-16-34-82(96,3)81(110)84-35-32-53-20-22-55(23-21-53)48-94(71(102)31-30-69(100)87-51)37-13-9-8-12-36-93-49-58(44-64(79(95)108)89-75(62)104)61-45-59(83)26-29-66(61)93/h15,17-18,20-29,41,45,49,51-52,62-65,67,72-73,98H,8-14,16,19,30-40,42-44,46-48,50H2,1-7H3,(H8-,84,85,86,87,88,89,90,91,92,99,100,101,103,104,105,106,107,110)/p+1/t51-,52+,62-,63-,64-,65+,67-,72-,73-,82-/m0/s1
InChI Key ZJMSWDDEBKNMLX-HMPNVHCESA-O

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
proprotein convertase subtilisin/kexin type 9 Hs Inhibitor Binding 11.3 pKi - 4
pKi 11.3 (Ki 5x10-12 M) [4]
Description: Binding affinity for hPCSK9 determined in a TR-FRET assay